Seeking Alpha

Seeking Alpha Portfolio App for iPad

LATEST ARTICLES

ARTICLES | NEWS | TRANSCRIPTS

ABB: Solid Growth And Investment Opportunity
Delian Naydenov • GE, SI, ABB • Tue, May 14, 13:01 ET
UBS Shows The Strength Of Its New Business Model With Solid Q1 Results
Trefis • UBS • Wed, May 1, 18:15 ET
Beaten Down Logitech Has Significant Upside Potential
Matthew Dow • LOGI • Tue, Apr 30, 14:25 ET
ABB Acquires Power-One To Lead Solar Inverter Market
Alpha Hunter • MW, PWER, ABB • Wed, Apr 24, 14:10 ET
The Company Built To Survive A Second Great Depression
Tim McAleenan Jr. • GE, GIS, UNP • Tue, Apr 23, 14:02 ET
ABB Group Makes Excellent Strategic Acquisition Of Power-One
The Value Investor • PWER, ABB • Tue, Apr 23, 10:54 ET
Novartis AG's New Medicine Approval Looks Interesting
StockBaller • NVS • Mon, Apr 22, 05:53 ET
Roche's Oncology Unit Drives Strong Results And Tamiflu Strength Surprises
Trefis • RHHBY.OB • Fri, Apr 12, 11:57 ET
Roche Earnings Preview: What We Are Watching
Trefis • RHHBY.OB • Tue, Apr 9, 15:06 ET
Novartis Loses The Glivec Patent Fight In India
Derek Lowe • NVS • Mon, Apr 1, 16:52 ET
Roche Mulls Bid For Genetic Sequencing Company Life Technologies
Trefis • LIFE, RHHBY.OB • Mon, Apr 1, 13:17 ET
Novartis' Patent Denial
Profit Fan • NVS • Mon, Apr 1, 10:55 ET
3 Reasons To Buy This Leading Drug Stock Right Now
StreetAuthority • PFE, VRTX, NVS • Fri, Mar 22, 14:30 ET
Roche Holdings: New Drugs Drive Oncology Unit's Growth
Trefis • RHHBY.OB • Fri, Mar 15, 18:17 ET
Swiss Franc ETF Lower As SNB 'Stands Ready' On Further Purchases
Tom Lydon • FXF • Thu, Mar 14, 15:41 ET
Swiss Franc Set For Prolonged Weakness As SNB Reiterates Price Floor
Richard Cox • FXF • Thu, Mar 14, 15:04 ET
Swiss Helvetia Offers Swiss Blue Chips At A 13% Discount
Robert Lewis • NSRGY.PK, RHHBY.OB, NVS • Thu, Mar 14, 09:15 ET
Roche, Genentech And The Cancer Drug Billionaires
Peter Geschek • RHHBY.OB, NVS • Thu, Feb 28, 14:09 ET
ABB Ltd.: A Mix Of Stability And Growth
Jason Cimpl • ABB • Mon, Feb 25, 17:37 ET
Skepticism About ABB Means There's Still Time To Buy
Stephen Simpson • ETN, SI, EMR • Tue, Feb 19, 12:53 ET
Roche Holding: Revised $58 Price Estimate On Strong Pipeline
Trefis • RHHBY.OB • Thu, Feb 14, 19:17 ET
Revising Credit Suisse Estimate To $32 On Outlook, Despite Mixed Results
Trefis • CS • Fri, Feb 8, 16:22 ET
Will The Flu Vaccine Race Send Novartis Higher?
IncomeHunter • INO, MRK, SNY • Thu, Feb 7, 10:41 ET
Novartis A Buy Thanks To Its Slow And Steady Dividend Growth
Jeroen Jongbloed • NVS • Thu, Feb 7, 06:11 ET
'There's A Good Awareness Of Risk'
Karl Denninger • UBS • Mon, Jan 28, 02:30 ET
Reiterating A Positive Outlook For ABB
Delian Naydenov • SI, GE, ABB • Tue, Jan 15, 04:21 ET
Novartis Improves Its Oncology Pipeline With Cutting Edge Technology
Brian L. Wilson • ABLYF.PK, NVS • Thu, Jan 10, 13:36 ET
Swiss Franc Outlook For 2013
Forex Abode • FXF • Sat, Jan 5, 01:27 ET
A Little Known Way To Buy Nestle, Roche And Novartis For 85 Cents On The Dollar
George Spritzer • NSRGY.PK, NVS, RHHBY.OB • Mon, Dec 24, 2012, 04:21 ET
Buy Novartis For A Safe Dividend Yield
Horizon Investments • AZN, BMY, GSK • Fri, Dec 21, 2012, 05:32 ET
Buy Logitech, It Will Crush 2013 And 2014
Alex Cho • LOGI • Fri, Dec 21, 2012, 03:52 ET
UBS's Lies
Felix Salmon • BCS, UBS • Wed, Dec 19, 2012, 17:46 ET
Swiss Franc ETF Rises As Banks Charge For Deposits
Tom Lydon • FXF • Tue, Dec 18, 2012, 17:30 ET
Outlook On SNB Monetary Policy Assessment Meeting
George Dorgan • EWL, NSRGY.PK, NVS • Wed, Dec 12, 2012, 11:32 ET
Leading Swiss Banks Navigate Scandals And Shrinking Business
Peter Pham • CS, UBS • Sun, Dec 9, 2012, 02:06 ET
Capital Controls
Marc Chandler • FXF • Mon, Dec 3, 2012, 14:00 ET
Novartis Moving Forward In Generics
Peter Pham • PFE, TEVA, NVS • Mon, Dec 3, 2012, 10:32 ET
All You Ever Wanted To Know About The Swiss Trade Surplus
George Dorgan • EWL, NSRGY.PK, NVS • Thu, Nov 29, 2012, 11:36 ET
Buy Novartis: A Dividend Gem In The Pharmaceutical Industry
Qineqt • PFE, SNY, NVS • Tue, Nov 27, 2012, 12:05 ET
China Biotech In Review: Henan Province Starts $40 Million Biological Fund
ChinaBio Today • RHHBY.OB • Sun, Nov 25, 2012, 07:58 ET
The Secret To HVDC Grids: ABB Unveils HVDC Circuit Breaker
Greentech Media • ABB • Mon, Nov 12, 2012, 14:45 ET
AHA - 2 Hits And Several Misses With Novartis' Serelaxin
EP Vantage • NVS • Wed, Nov 7, 2012, 11:24 ET
UBS AG: Bottom Line Improves
Qineqt • UBS • Thu, Nov 1, 2012, 09:46 ET
Novartis AG: Establish Long-Term Positions With 6.23% Discount Through Options
Nick Chiu • PFE, NVS • Mon, Oct 29, 2012, 19:07 ET
Swiss And German Economic Indicators, October 2012
George Dorgan • FXF, EUO • Sun, Oct 28, 2012, 15:30 ET
Is The Swiss Franc Overvalued? Purchasing Power Parity
George Dorgan • BNO, DRR, FXS • Wed, Oct 17, 2012, 14:36 ET
3 Reasons Novartis Creates Long-Term Opportunity
ValueMax • AZN, GSK, MRK • Wed, Oct 17, 2012, 12:31 ET
Are Commodity Trading Firms Too Big To Fail?
Craig Pirrong • GLCNF.PK • Mon, Oct 15, 2012, 04:24 ET
Novartis: Breaking Conglomerate Structure Could Unlock 50-60% Shareholder Returns
Pharma Intelligence • NVS • Wed, Oct 10, 2012, 09:15 ET
Is Standard And Poor's A Rating Agency Or A Rumor Agency?
George Dorgan • BNO, DRR, JYN • Tue, Oct 9, 2012, 10:41 ET

First Page
Previous Page
1 - 50 of 565
Next Page
Last Page